Optimizatsiya vedeniya bol'nykh khronicheskim gepatitom V na ambulatornom etape
- Autores: Russkikh A.V.1
-
Afiliações:
- Edição: Nº 10 (2012)
- Páginas: 26-30
- Seção: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/279611
- ID: 279611
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
The article considers the epidemiology and principles of serological monitoring of chronic hepatitis B (CHB), features of diagnosis of this disease in outpatient settings, and its clinical picture. Approaches to optimization of management of chronic hepatitis B patients at the outpatient treatment stage including collaboration of various specialists and criteria for antiviral therapy are presented.
Palavras-chave
Texto integral
Bibliografia
- Брико Н.И. Эпидемиология парентеральных гепатитов В и С // Бюлл. Вакцинация 2001. № 6. С. 26-32.
- Simonetti J, Bulkow L, McMahon BJ, et al. Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohor chronically infected with hepatitis B virus. Hepatology 2010;51:1531-37.
- Абдурахманов Д.Т. Хронический гепатит B и D. М., 2010.
- Liu J, Yang H-L, Lee M-H, et al. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study. Gastroenterology 2010;139:474-82.
- Брико Н.И. Методические основы оценки социально-экономической эффективности вакцинопрофилактики гепатита В // Медицинская кафедра. 2003. № 2. С. 53-54.
- Hoofnagle JH, Doo E, Liang TJ, et al. Management of hepatitis B: summary of a clinical research workshop. Hepatology 2007;45:1056-75.
- McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology 2009;49:S45-S55.
- Liaw YF, Chu CM. Hepatitis B virus infection. Lancet 2009;373:582-92.
- Lok ASF, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009;50:661-62.
- Liu J, Yang H-L, Lee M-H, et al. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a communitybased follow-up study. Gastroenterology 2010;139(2):474-82.
- Yuen MF, Wong DKH, Fung J, et al. HBsAg sero-clearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma. Gastroenterology 2008;135:1192-99.
- Brunetto MR, Moriconi F, Bonino F, et al. Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B. Hepatology 2009;49:1141-50.
- Keeffe EB, Dieterich DT, Han SHB, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol 2008;6:1315-41.
Arquivos suplementares
